Close sub navigation
Life at Verily
Close sub navigation
Code of Conduct
Terms of Service
Responsible Supply Chain
Learn about our work on COVID-19
Healthy at Work Launches Vaccine Management Tool
“When will I get vaccinated?”
Verily Partners with Janssen to Launch COVID-19 Immune Response Study
Onduo is on a mission to make "healthy" easy
Onduo, a Verily subsidiary, announced today that the company is building on the...
Project Baseline COVID-19 Testing Now Available to Children Ages 4 and Older
COVID-19 Winter Outlook and Vaccine Predictions with Dr. Bob Wachter
Inside Verily's CLIA Lab with Deb Hanks
DCRI, Verily, and HERO Registry to Support Long-Term Safety Study of COVID-19 Vaccine
Baseline COVID-19 Testing Program Now Available to Teens Ages 13 and Older
Research Goes Red: How feeling & emotions differ by age and through the experience of the COVID-19 pandemic
Baseline Sleep Mission results
Over 1,000 Baseline Health Study volunteers contributed 12,269 nights of sleep data to...
Verily welcomes Stephen Gillett as Chief Operating Officer to increase operational excellence
As Smart Lens program matures, Verily takes over program for next phase of development
How COVID-19 Research Project members are connecting with friends and family
Our latest survey of over 17,000 participants in the COVID-19 Research Project...
Singapore Prime Minister Lee Hsien Loong visits Verily’s mosquito sex sorting operations at the Environmental Health Institute
Your COVID-19 Questions Answered
Baseline COVID-19 Testing Program hits milestone with millionth test!
Reasons to have Confidence in the COVID-19 Vaccine Trials
Verily receives Emergency Use Authorization (EUA) for pooled testing and publishes COVID-19 guidance
Waymo: Providing COVID-19 testing to our team in partnership with Verily
The health and safety of our team is our top priority as we continue to navigate the...
COVID-19, women and altruism
COVID-19 Research Project: findings on well-being and social distancing
Project Baseline Health Study’s Innovative Approach Highlighted in Nature
Verily stands up CLIA-certified lab focused on COVID-19 testing
An interview with Deb Hanks, MD, Verily’s head of Pathology
Verily welcomes Cynthia Patton as General Counsel
Returning heart health data to Health Study participants
A Look At The COVID-19 Research Community
More than 31,000 members across 49 states joined the COVID-19 Research Project in the...
Verily launches study to evaluate an obstructive sleep apnea (OSA) management platform
Verily Expands Baseline COVID-19 Testing Program to 130 Locations Nationwide, Providing Over 256,844 Tests
Why Testing Matters
An interview with Verily’s Head of Biostatistics & Epidemiology
Verily’s Project Baseline: Ready to Support Healthcare Workers and the HERO Research Program
New Baseline COVID-19 Research Project launches
Advancing scientific understanding of virus, with initial focus on antibody testing
Verily undertakes cybersecurity center of excellence with Stephen Gillett at the helm
Verily’s support of Rite Aid’s expansion of COVID-19 test sites
Health disparities intensified by the COVID-19 pandemic and efforts to mitigate
Verily launches COVID-19 Pathfinder to automate frontline support
Verily’s Baseline Platform: Investing in Security and Privacy
Understanding public health in the time of COVID-19
Developing smarter COVID-19 testing to inform public health
The Baseline COVID-19 Program releases guide for establishing community testing
Baseline COVID-19 Pilot Program shares early screening and testing progress
The Project Baseline COVID-19 Program: Responding to a health crisis
Verily collaborates with CA Governor's office, federal and local public health authorities on COVID-19
Verily Study Watch AFib clearance
Verily receives FDA 510(k) clearance for Study Watch with Irregular Pulse Monitor
Better data, better care
By finding new ways to collect, organize and activate data, we can have a meaningful...
Verily welcomes Deepak Ahuja as Chief Financial Officer
Onduo and scaling the virtual care model
Growing the virtual care model across the spectrum of health.
A new way to see disease
Learn about our end-to-end platform for mapping the molecular geography of tissue biopsies.
Verily Advisory Board Series: Dennis Ausiello on Understanding Wellness and its Progression to Disease
Redesigning participant onboarding to put the user first
Reimagining the participant experience for people with type 2 diabetes.
DeepMass: A new machine learning method for the characterization of proteins
Exploring one of the first applications of deep learning to the field of mass spectrometry.
Going big with nanoparticle technology in coronary artery disease
Engineering drug delivery with nanoparticle technology in coronary artery disease
Visiting the Personalized Parkinson's Project
Question convention responsibly: how Verily is tackling data and privacy
Meaningful use of data in healthcare, and the precautions that come with it
Collaborating with the American Heart Association to include more women in research
Launching a powerful new screening tool for diabetic eye disease in India
Capturing health information with Study Watch
Launching an investigational device to capture health info for clinical research
Seeing the future of ocular devices
Developing smart ocular devices with Alcon to help improve everyday health routines
Deepening our understanding of MS with biosensors
A brand new approach to heart health
Working with the American Heart Association & Astrazeneca to reverse coronary heart disease.
Mapping the immune system
Using advanced computational analysis to generate detailed immune system profiles.
Tracking Parkinson’s Disease
A multi-year study to explore the factors that impact the course of Parkinson's disease.
Giving back through Verily Serve
Verily Serve is a week-long annual volunteering event centered around giving back
Partnering to develop innovative solutions for monitoring atrial fibrillation
Early detection for diabetic retinopathy and diabetic macular edema
Employee Spotlight: Meet Richard Stewart, Head of Regulatory Affairs